Funding news · Oct 1, 2026
Devoted Health Raises $1.2B Series C+ for Medicare Advantage
Devoted Health Raises $1.2B Series C+ for Medicare Advantage
Devoted Health, a Medicare Advantage insurance company, has raised $1.2 billion in a Series C+ funding round. The funding date is October 1, 2026. No lead investor was disclosed, and the list of investors is empty.
What Devoted Health Does
Devoted Health combines technology and personalized care to improve healthcare for seniors. As a Medicare Advantage insurance company, it focuses on delivering better health outcomes for its members.
Funding Details
- Round type: Series C+
- Amount: $1,200,000,000 (USD)
- Lead investor: Not disclosed
- Investors: None listed
- Funding date: October 1, 2026
Why This Matters
This is a massive round for a Medicare Advantage company. The $1.2 billion Series C+ indicates significant capital infusion to support Devoted Health's growth and operations. The absence of a disclosed lead investor is notable, but the sheer size of the round suggests strong interest from multiple parties.
For acquisition watchers, this round positions Devoted Health with substantial resources to expand its Medicare Advantage offerings. The company operates in a highly regulated and competitive space, where technology and personalized care are key differentiators.
About Devoted Health
Devoted Health is a Medicare Advantage insurance company that combines technology and personalized care to improve healthcare for seniors. Its domain is devoted.com. The company's funding stage is listed as Series C+.
Context
No source URL was provided for this funding announcement. The round type is Series C+, and the amount is $1.2 billion USD. No lead investor or other investors were named.
This article is based solely on the funding and company information provided. No additional investors, amounts, or terms were disclosed.